CDEK
← All trials

NCT03070886

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
Jan 16, 2017
Primary completion
May 1, 2026
Completion date
—
First posted
—
Last posted
—
Enrollment
612
Arms / groups
2 / —
Source
AACT · pre-existing

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.